Journal of Pure and Applied Microbiology, 2020 Interleukin-35 (IL-35), secreted mainly by T-regulatory cells (T-regs), has been considered to have immunosuppressive actions in many auto-immune diseases and tumors.
Safaa S. Abo-Elnour +5 more
doaj +2 more sources
Interleukin-35 and Thymoquinone nanoparticle-based intervention for liver protection against paracetamol-induced liver injury in rats. [PDF]
Saudi J Biol Sci, 2023 Paracetamol (PAR) is a commonly used antipyretic and analgesic agent, but its excessive usage can induce liver damage and major health consequences.
Abduh MS +6 more
europepmc +2 more sources
Different expression levels of interleukin-35 in asthma phenotypes [PDF]
Respiratory Research, 2020 Background Interleukin (IL)-35 is a newly discovered inhibitory cytokine which is produced by regulatory B and T lymphocytes and belongs to the IL-12 family.
Wei Li, Ruihan Gao, Tong Xin, Peng Gao
doaj +2 more sources
Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis [PDF]
Frontiers in Immunology, 2020 Corticosteroids are effective therapy for autoimmune diseases but serious adverse effects preclude their prolonged use. However, immune-suppressive biologics that inhibit lymphoid proliferation are now in use as corticosteroid sparing-agents but with ...
Minkyung Kang +4 more
doaj +2 more sources
Urine and serum interleukin 35 as potential biomarkers of lupus nephritis [PDF]
Central European Journal of Immunology, 2021 Mary Atef Nassif
doaj +2 more sources
Expression of interleukin-35 and type 2 cytokines in children with acute allergic asthma [PDF]
Iranian Journal of Immunology, 2021 Background: Allergic asthma is believed to be a T helper 2 cell (Th2) preponderant response caused by airway hyper-responsiveness. Interleukin-35 (IL-35) is a newly discovered anti-inflammatory cytokine.
Zhangqiao Cai, Xuxia He, Jing Yang
doaj +1 more source
Association of Interleukin-32α with Interleukin-35 and Transforming Growth Factor-β Produced by the Peripheral Blood Mononuclear Cells from Patients with Type 2 Diabetes Mellitus [PDF]
پزشکی بالینی ابن سینا, 2023 Background and Objective: Cytokine production was shown to be changed in Type 2 diabetes mellitus (T2DM). Nonetheless, the relationship of pro-inflammatory interleukin (IL)-32α with anti-inflammatory IL-35 and transforming growth factor (TGF)-β is ...
Vida Sheikh +2 more
doaj
Interleukin-35 Levels in Patients with Stable Coronary Artery Disease
, 2022 Background It has been shown that interleukin-35 (IL-35) subunits are strongly expressed in atherosclerotic plaques in humans. Therefore, it is considered to play a role in atherosclerosis. Objectives In this study, IL-35 levels were compared with the
Bulent Demir (12698615) +7 more
core +1 more source
Impact of angiotensin converting enzyme inhibition on post- coronary artery bypass interleukin 6 release [PDF]
, 2002 Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti- inflammatory action.
Humphries, S.E. +5 more
core +8 more sources
, 2003 Interleukin-18 (IL-18), a recently described member of the IL-1 cytokine superfamily, is now recognized as an important regulator of innate and acquired immune responses.
McInnes, I.B. +2 more
core +1 more source